Litcius/Paper detail

The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice

Gabriela Alves Moreira, Mônica Maria Magalhães Caetano, Juliana A. Vale, Janine Cerqueira de Paiva, Victor Hugo Sousa Gonçalves, Alisson Andrade Almeida, Lucas Viana Gomes Silva, Fernanda Rebellato Giordano Martim, Marcus Vinícius de Andrade Barros, Gabriela Guimarães, Leandro de Oliveira Santos, Ana Paula Martins de Souza, Mariana Machado‐Neves, Róbson Ricardo Teixeira, Abelardo Silva‐Júnior, Juliana Lopes Rangel Fietto, Mariana Boroni, Leandro Licursi de Oliveira, Gustavo Costa Bressan

2022Biochemical Pharmacology15 citationsDOI

Topics & Concepts

Immune systemMelanomaCancer researchMetastasisMidkineTumor microenvironmentBiologyImmunologyCancerReceptorGeneticsBiochemistryGrowth factorCAR-T cell therapy researchCell Adhesion Molecules ResearchImmunotherapy and Immune Responses